A conversation with Spencer Hawkswell of Therapsil about his organization’s effort to gain psychedelic exemptions for terminally ill patients.
Share this post
A conversation with Spencer Hawkswell of Therapsil about his organization’s effort to gain psychedelic exemptions for terminally ill patients.